Varian Inc.
Varian Inc. of Palo Alto, Calif., has
acquired Fourier transform mass spectrometry technology through its purchase of
IonSpec Corp. of Lake Forest, Calif. The technique is used in laboratories to discover
the function and structural characterization of proteins and other biomolecules.
The information provides scientists with fundamental knowledge of how cells work
and how diseases evolve, leading to new diagnostic research and drug targets. The
company expects the agreement to facilitate the expansion of its technology portfolio
and to increase participation in the study of proteins, nucleic acids and drug metabolites.
LATEST NEWS
- CLEO Heads to the East Coast
Apr 29, 2024
- Laser-Based Gas Analyzer Developed to Detect Air Pollution
Apr 29, 2024
- Qubits Could be Stored in Flash-Like Memory
Apr 29, 2024
- Exail Signs LLNL Contract, Partners with Eelume
Apr 26, 2024
- Menlo Moves U.S. HQ: Week in Brief: 4/26/2024
Apr 26, 2024
- Optofluidics Platform Keys Label-, Amplification-Free Rapid Diagnostic Tool
Apr 25, 2024
- DUV Lasers Made with Nonlinear Crystals Enhance Lithography Performance
Apr 25, 2024
- Teledyne e2v, Airy3D Collaborate on 3D Vision Solutions
Apr 24, 2024